| CRISPR Medicine | This is an overview of articles on base editors
Leber congenital amaurosis is a group of rare inherited retinal diseases that lead to blindness over time. Treatment options are limited,...
The CRISPR gene-editing therapy more than doubled the lifespan in a mouse model by tackling the root cause of Hutchinson-Gilford progeria. The new...
Kevin Davies, author and Executive Editor of The CRISPR Journal, says that CRISPR is as close as doctors may be able to get to the Holy Grail of...
Professor Waseem Qasim, of University College London and Great Ormond Street Institute of Child Health, helps run early-phase clinical trials using...
Off-target editing is a significant problem with CRISPR and something that scientists really want to protect genomes from. And protection is exactly...
In this roundup, we look back on our interviews with scientists who are making strides in developing CRISPR-based cures for genetic diseases.
All gene therapies have their own advantages and limitations, but one shared feature is the challenge in delivering the gene-editing or replacement...
For the first time, scientists have seen high-resolution molecular details of a CRISPR-Cas9 base editor biting down on its DNA target. The structure...
